Silencing of XB130 Is Associated with Both the Prognosis and Chemosensitivity of Gastric Cancer

XB130 is a newly characterized adaptor protein that was reported to promote thyroid tumor growth, but its role in the progression of other kinds of cancer such as gastric cancer (GC) remains unknown. Accordingly, we investigated the association between XB130 expression and the prognosis of GC patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Min, Huang, Weizhen, Lin, Li, Zheng, Dayong, Zuo, Qiang, Wang, Lin, Wang, Nina, Wu, Yajun, Liao, Yulin, Liao, Wangjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3426513/
https://www.ncbi.nlm.nih.gov/pubmed/22927913
http://dx.doi.org/10.1371/journal.pone.0041660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3426513/
https://www.ncbi.nlm.nih.gov/pubmed/22927913
http://dx.doi.org/10.1371/journal.pone.0041660

Ejemplares similares